CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03028636
NCT03028636N/ACompleted
CompareCT.gov

LIBERATE - PRO: An Extended Use Registry to Further Develop Understanding of the Long Term Use of the Eclipse™ System for Fecal Incontinence in Women Via Patient Reported Outcomes

Pelvalon, Inc.·observational·Posted Jan 23, 2017·Updated Jan 28, 2020

In Brief

An observational study for Fecal Incontinence and 3 related conditions. Completed, enrolled 17 participants across 1 site.

Detailed Summary

A prospective, open label post market registry to collect Patient Reported Outcomes in an online data capture registry, maintained by Pelvalon, of women with fecal incontinence exiting the LIBERATE study (NCT02428595) continuing to use the Eclipse System for bowel control.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFecal Incontinence, Bowel Dysfunction, Bowel Incontinence, Accidental Bowel Leakage
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 23, 2017
Enrollment StartSep 19, 2016
Primary CompletionFeb 27, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.4 years ago